It sounded like that trial would need to be changed or possibly even stopped (they were asked about stopping it on the call I don't recall but think they got a vague standard sort of reply).
I think this is the cubed trial so there was squared, cubed what comes next?
Dr. Rothblatt said it would be foolish to stop Oral and thinks its just a delay of a couple years (4-5 and then later said maybe even 1-2). I still think they would be better off going to the drawing board. Even if it gets approved with the type of efficacy and tolerability they are showing its not going to do well. The big thing though is the delay to do that and the IP situation with Remodulin and to a lesser extent Tadalafil too.
News 
Market Data 
Discover 
AI
